tirzepatide arthritis Results of the phase 3b TOGETHER-PsA trial showed ixekizumab administered together with in comorbid overweight or obese adults with psoriatic showed clinically meaningful improvement of psoriatic disease, physical function, weight TOGETHER-PsA:Tirzepatide + Ixekizumab Rapidly Improves
Pay in 4 interest-free payments of $5.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




























